208111-98-2 Usage
General Description
This chemical compound, "(3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-2-one", is an organic substance distinguished by its specific structural arrangement and functional groups. Noteworthy elements of its structure include a hexahydro segment reflecting six hydrogen atoms in its composition, a benzoyloxy functional group (an ester of benzoic acid), and a trifluoromethyl group (indicating the presence of three fluorine atoms). Additionally, it features a butenyl side chain, a 3-oxo group, and a cyclopenta[b]furan-2-one ring, replete with a carbonyl function at the 2-position. As for its stereochemistry, the compound has specific configurations at the 3a, 4, 5, and 6a positions, denoted by the R and S descriptors that follow the Cahn-Ingold-Prelog priority rules. Due to its complex structure, this chemical may have applications in various research and development areas, though specific uses are to be determined based on further experimental data and context.
Check Digit Verification of cas no
The CAS Registry Mumber 208111-98-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,8,1,1 and 1 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 208111-98:
(8*2)+(7*0)+(6*8)+(5*1)+(4*1)+(3*1)+(2*9)+(1*8)=102
102 % 10 = 2
So 208111-98-2 is a valid CAS Registry Number.
InChI:InChI=1/C25H21F3O6/c26-25(27,28)16-7-4-8-18(11-16)32-14-17(29)9-10-19-20-12-23(30)33-22(20)13-21(19)34-24(31)15-5-2-1-3-6-15/h1-11,19-22H,12-14H2/b10-9+/t19-,20-,21-,22+/m1/s1
208111-98-2Relevant articles and documents
Improved Process for the Production of Prostaglandins and Prostaglandin Analogs
-
Page/Page column 58, (2010/01/29)
The present invention relates to an improved process for the production of prostaglandins and prostaglandin analogs. In particular, this invention relates to the production of prostaglandins of the PGF2α-series, including latanoprost, travoprost, and bimatoprost, which are active pharmaceutical ingredients used for the reduction of elevated intraocular pressure in patients with glaucoma and ocular hypertension.
